Medicare Rx and the Sequester Impact: Making Headlines, But is There a Commercial Impact?
This article was originally published in RPM Report
Two large pharmaceutical manufacturers weigh in on whether the sequester is impacting their injectables business. The answer so far: not really. The same story goes for the sequester and Part D, though Lilly is seeing higher than expected Part D discounts in 2013.